Publisher
Springer Berlin Heidelberg
Reference128 articles.
1. Abramson DH, Ellsworth RM, Kitchin FD et al. (1984) Second nonocular tumors in retinoblastoma survivors: Are they radiation-induced? Ophthalmology 91: 1351–1355
2. Anderson PM,Wiseman GA, Dispenzeri A et al. (2002) High-dose samarium-153 ethylene diamine tetramethylene phosphonate: Low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.) Clin Oncol 20: 189–196
3. Bacci G, Picci P, Avella M et al. (1990a) The importance of dose-intensity in neoadjuvant chemotherapy of osteosarcoma: A retrospective analysis of high-dose methotrexate, cisplatinum and adriamycin used preoperatively.) Chemotherapy 2: 127–135
4. Bacci G, Picci P, Ruggeri P, Mercuri M, Avella M et al. (1990b) Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Instituto Rizzoli experience in 127 patients treated preoperatively with intravenous methotrexate (high vs. moderate doses) and intraarterial cisplatin. Cancer 65: 25392553
5. Bacci G,Picci P, Ferrari Setal. (1993) Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities: Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin. Cancer 72: 3227–3238